hASH1 is a specific immunohistochemical marker for lung neuroendocrine tumors
Ye, Bo, MD, PhD, Cappel, Jaclyn, MD, Findeis-Hosey, Jennifer, MD, McMahon, Loralee, MS, Yang, Qi, AAS, Xiao, Guang-Qian, MD, PhD, Xu, Haodong, MD, PhD, Li, Faqian, MD, PhD
Published in Human pathology (01.02.2016)
Published in Human pathology (01.02.2016)
Get full text
Journal Article
Down-regulation of cytoplasmic PLZF correlates with high tumor grade and tumor aggression in non–small cell lung carcinoma
Xiao, Guang-Qian, MD, PhD, Li, Faqian, MD, PhD, Findeis-Hosey, Jennifer, MD, Hyrien, Ollivier, PhD, Unger, Pamela D., MD, Xiao, Lu, MD, Dunne, Richard, MD, Kim, Eric S., MD, Yang, Qi, MS, McMahon, Loralee, MS, Burstein, David E., MD
Published in Human pathology (01.11.2015)
Published in Human pathology (01.11.2015)
Get full text
Journal Article
Comparison of PD-L1 Immunostaining for Non-small Cell Carcinoma of the Lung Between Paired Cytological and Surgical Specimens
Bratton, Laura, MD, Russell, Donna, MEd, CT(ASCP)HT, Yong, Qi, McMahon, Loralee, MS, Zhou, Zhongren, MD, PhD
Published in Journal of the American Society of Cytopathology JASC (01.09.2016)
Published in Journal of the American Society of Cytopathology JASC (01.09.2016)
Get full text
Journal Article
GATA binding protein 3 is down-regulated in bladder cancer yet strong expression is an independent predictor of poor prognosis in invasive tumor
Miyamoto, Hiroshi, MD, PhD, Izumi, Koji, MD, Yao, Jorge L., MD, Li, Yi, MD, Yang, Qi, AAS, McMahon, Loralee A., MS, Gonzalez-Roibon, Nilda, MD, Hicks, David G., MD, Tacha, David, PhD, Netto, George J., MD
Published in Human pathology (01.11.2012)
Published in Human pathology (01.11.2012)
Get full text
Journal Article